Neuro-endocrine and immuno-systems activation during coronary surgery

ISRCTN ISRCTN78040136
DOI https://doi.org/10.1186/ISRCTN78040136
Secondary identifying numbers N0264149435
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
15/03/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr R Ascione
Scientific

c/o Research & Effectiveness Department
Level 1, The Old Building
Bristol Royal Infirmary
Malborough Street
Bristol
BS2 8HW
United Kingdom

Phone +44 (0)117 928 3473
Email r&eoffice@ubht.swest.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Scientific titleNeuro-endocrine and immuno-systems activation during coronary surgery
Study objectivesTo ascertain the effects of cardiopulmonary bypass (CPB) and cardioplegic arrest on the activation of the hypothalmic-pituatary-adrenal (HPA) system and on the relations between neuro endocrine and immune systems
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCoronary artery bypass grafting (CABG)
InterventionProspective randomised study patients randomised to:
1. With cardiopulmonary bypass
2. Without cardiopulmonary bypass
Intervention typeProcedure/Surgery
Primary outcome measureTo characterise the HPA system response during coronary surgery with or without cardiopulmonary bypass.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/08/2004
Completion date31/07/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants80
Key inclusion criteria80 patients admitted for first time coronary artery surgery suitable for on or off CPB surgery
Key exclusion criteria1. Single vessel coronary disease
2. Emergency referral
3. Previous Coronary Artery Graft Bypass (CAGB)
4. Evidence of severe thoracic disease
Date of first enrolment01/08/2004
Date of final enrolment31/07/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

c/o Research & Effectiveness Department
Bristol
BS2 8HW
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

United Bristol Healthcare NHS Trust (UK)

No information available

NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

15/03/2016: No publications found, verifying study status with principal investigator